维普期刊资源整合服务平台（V6.5）

47篇 您的检索式：作者名="Overmoyer"

选中清除导出查看参考文献查看引证文献引用追踪共3页首页上一页第1页下一页末页 /3 跳转

	题名	作者	年代	出处	被引量
1	Breast conservation sur- gery achieving> or = 2 mm tumor-free margins results in de-creased localregiona] recurrence rates 显示文摘	Kunos C Latson L Overmoyer B	2006	Breast2006，12，：	1
2	Inflammatory breast cancer as a model disease to study tumor angiogenesis:results of a phase IB trial of combination SU5416 and doxorubicin显示文摘	Overmoyer B Fu P Hoppel C		0，，：	1
3	Randomized phase Ⅲ stud y of docetaxel compared with paclitaxel in metastatic breast cancer 显示文摘	Jones SE Erban J Overmoyer B	2005	J Clin Oncol2005，23，24：	1
4	Phase Ⅲ comparison of docetaxel and paclitaxel in patiens with metastatic breast eaneer显示文摘	RAVDIN P ERBAN J OVERMOYER B	2003	EarJ Cancer2003，1，5：	1
5	Dose-dense doxorubin and docetaxel for patients with advanced operable and inoperable breast cancer显示文摘	Cooper B Silverman P Overmoyer B	2003	Proc Am Soc Clin Oncol2003，22，1：	1
6	Randomized phaseⅢstudy of docetaxel compared with paclitaxel in metastatic breast cancer显示文摘	Jones S E Erban B Overmoyer G T	2005	J Clin Oncol2005，23，24：	1
7	Randomized phase III study of docetaxel compared with paclitaxel in metastatic Breast cancer显示文摘	Jones SE Erban J Overmoyer B	2005	J Clin Oncol2005，23，55：	1
8	Randomized phase III stud-y of docetaxel compared with paclitaxel in metastatic breast cancer显示文摘	Jones SE Erban J Overmoyer B	2005	J Clin Oncol2005，23，24：	1
9	Randomized Phase III Study of Docetaxel Compared With Paclitaxel in Metastatic Breast Cancer 显示文摘	Jones SE Erban J Overmoyer B	2005	J Clin Oncol2005，23，：	1
10	Chemotherapeutic palliative approaches in the treatment of brest 'cancer 显示文摘	Overmoyer BA	1995	Semi Oncol1995，22，23：	1
11	Chemotherapeutic palliative approaches in the treatment of breast cancer显示文摘	OVERMOYER BA	1995	Semi Oncol1995，22，23：	1
12	Breast conservation surgery achieving >or =2mm tumor-free margins results in decreased local-regional recurrence rates显示文摘	Kunos C Latson L Overmoyer B	2006	Breast J2006，12，1：	1
13	A phase II trial of the PARP inhibitor veliparib (ABT888) and temozolomide for metastatic breast Cancer 显示文摘	Isakoff SJ Overmoyer B Tung NM	2010	J Clin Oncol2010，28，15：	1
14	A phase 11 trial of the PARP inhibitor veliparib (ABT888) and temozolamide for metastatic breast cancer显示文摘	Isakoff S J Overmoyer B Tung N M	2010	J Clin Oneol2010，28，：	1
15	Relationships between asyunnetries in functional movements and the star excursion balance test 显示文摘	Overmoyer GV Reiser RF 2nd	2013	J Strength Cond Res2013，27，7：	1
16	Randomized trial tom-panng docetaxel and paelitaxel in patients with metastatic hreast cancer显示文摘	Jones S Erban J Overmoyer B	2003	The 26th Annual SanAntoino Breast Cancer Symposium2003，10，1：	1
17	Pegylated liposomal doxorubicinand cyclophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer 显示文摘	OVERMOYER B SILVERMAN P HOLDER L W	2005	Clin Breast Cancer2005，6，2：	1
18	Pegylated liposomal doxorubiein and eyelophosphamide as first-line therapy for patients with metastatic or recurrent breast cancer显示文摘	Overmoyer B Silverman P Holder LW	2005	Clin Breast Cancer2005，6，2：	1
19	Inflammatory breast cancer: novel preoperativetherapies显示文摘	Overmoyer BA	2010	Clin Breast Cancer2010，10，1：	1
20	Chemotherapeutic palliative approachesin the treatment of breast cancer显示文摘	Overmoyer BA	1995	Semi Oncol1995，22，23：	1

返回顶部每页显示：

共3页首页上一页第1页下一页末页 /3 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示